Adcendo
adcendo.comLocations
Frederiksberg, Denmark
industry
Biotechnology
Size
51 - 200 employees
Stage
Series B
founded in
2017
Adcendo seeks to develop antibody-drug conjugates to create new medicines for cancer patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from the Finsen Laboratory of Rigshospitalet and the University of Copenhagen.
Something looks off?Open jobs at Adcendo
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.